Parallel Advisors
COCP icon

Parallel Advisors’s Cocrystal Pharma COCP Stock Holding History

Parallel Advisors’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.5K Hold
12,569
– – ﹤0.01% 2875
2026
Q2 		$13.2K Hold
12,569
– – ﹤0.01% 2812
2026
Q1 		$12.7K Hold
12,569
– – ﹤0.01% 2644
2025
Q4 		$12.3K Sell
12,569
-42
-0.3% -$44 ﹤0.01% 2519
2025
Q3 		$15.8K Sell
12,611
-2,617
-17% -$4.04K ﹤0.01% 2367
2025
Q2 		$22.7K Hold
15,228
– – ﹤0.01% 2131
2025
Q1 		$22.4K Hold
15,228
– – ﹤0.01% 2079
2024
Q4 		$30.8K Hold
15,228
– – ﹤0.01% 1926
2024
Q3 		$26.8K Buy
+15,228
New +$29.6K ﹤0.01% 1923
2023
Q3 		– Sell
-15,228
Closed -$36.4K – 3387
2023
Q2 		$36.4K Hold
15,228
– – ﹤0.01% 1560
2023
Q1 		$30.3K Hold
15,228
– – ﹤0.01% 1626
2022
Q4 		$29.7K Buy
15,228
+2
+0% +$5 ﹤0.01% 1525
2022
Q3 		$53K Hold
15,226
– – ﹤0.01% 1236
2022
Q2 		$75K Hold
15,226
– – ﹤0.01% 1071
2022
Q1 		$102K Hold
15,226
– – ﹤0.01% 982
2021
Q4 		$119K Hold
15,226
– – ﹤0.01% 941
2021
Q3 		$192K Sell
15,226
-166
-1% -$2.2K 0.01% 736
2021
Q2 		$231K Sell
15,392
-750
-5% -$11.4K 0.01% 632
2021
Q1 		$269K Sell
16,142
-709
-4% -$14.4K 0.01% 536
2020
Q4 		$275K Buy
16,851
+6,137
+57% +$85.2K 0.01% 490
2020
Q3 		$120K Hold
10,714
– – 0.01% 709
2020
Q2 		$195K Hold
10,714
– – 0.01% 545
2020
Q1 		$91K Buy
10,714
+6,619
+162% +$62.3K 0.01% 709
2019
Q4 		$24K Buy
4,095
+53
+1% +$529 ﹤0.01% 1311
2019
Q3 		$99K Buy
+4,042
New +$105K 0.01% 718

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Clean Yield Group
Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
NVWM LLC
NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Parallel Advisors's COCP Position: Q3 2026 in Review

Parallel Advisors held its Cocrystal Pharma (COCP) position steady in Q3 2026 at 12,569 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2875.

Parallel Advisors first reported a position in COCP in Q3 2019 and has held it in 25 quarters since. The position peaked at $275K in Q4 2020. 14 funds tracked by Wall St. Rank hold COCP as of Q3 2026.

  • Parallel Advisors held 12,569 shares of Cocrystal Pharma worth $14.5K as of Q3 2026.
  • Parallel Advisors left its Cocrystal Pharma share count unchanged in Q3 2026.
  • Cocrystal Pharma made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #2875 holding.
  • Parallel Advisors first reported a position in Cocrystal Pharma in Q3 2019 and has held it in 25 quarters since.
  • Parallel Advisors's Cocrystal Pharma position peaked at $275K in Q4 2020.
  • 14 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.